Energa SA (WSE:ENG)

Verve Therapeutics Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,358	5,673	3,876	2,915	3,168	3,263
Market Cap Growth	13.91%	46.37%	32.95%	-7.97%	-2.92%	11.30%
Enterprise Value	16,762	13,712	9,438	9,619	8,689	9,653
PE Ratio	14.84	18.60	6.28	3.02	3.27	-
PS Ratio	0.25	0.27	0.18	0.14	0.23	0.26
PB Ratio	0.41	0.45	0.31	0.25	0.32	0.37
P/FCF Ratio	8.36	-	-	-	3.21	11.87
P/OCF Ratio	0.92	1.33	3.76	0.73	0.87	1.26
EV/Sales Ratio	0.79	0.66	0.43	0.48	0.63	0.78
EV/EBITDA Ratio	5.64	4.76	3.44	3.99	3.79	5.49
EV/EBIT Ratio	9.76	7.90	5.65	6.86	6.56	11.77
EV/FCF Ratio	26.15	-	-	-	8.81	35.10
Debt / Equity Ratio	0.94	0.96	0.56	0.65	0.62	0.77
Debt / EBITDA Ratio	4.06	4.14	2.46	3.03	2.60	3.72
Debt / FCF Ratio	19.16	-	-	-	6.20	24.49
Quick Ratio	0.73	0.81	0.58	0.57	0.59	0.60
Current Ratio	0.88	0.88	0.65	0.62	0.64	0.67
Asset Turnover	0.64	0.62	0.75	0.83	0.67	0.61
Return on Equity (ROE)	2.47%	2.13%	5.05%	9.39%	10.03%	-4.93%
Return on Assets (ROA)	3.32%	3.22%	3.54%	3.62%	4.05%	2.52%
Return on Capital (ROIC)	4.84%	4.91%	5.44%	5.00%	5.25%	3.16%
Return on Capital Employed (ROCE)	6.40%	6.40%	8.90%	7.90%	8.00%	5.30%
Earnings Yield	6.74%	5.38%	15.92%	33.17%	30.56%	-12.04%
Earnings Yield	6.74%	5.38%	15.92%	33.17%	30.56%	-12.04%
FCF Yield	11.96%	-16.54%	-85.43%	-34.48%	31.13%	8.43%

Source: S&P Global Market Intelligence. Utility template. Financial Sources.